Insider NameBuy/SellCompany NameTickerAmountShares Change
Nov 15, 2018Nov 17, 2018Phillips Barclay A
SVP
CFO
SellG1 Therapeutics, Inc.GTHX$39.92$199,591-0
Jul 31, 2017Aug 01, 2017Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$0.89$1,831+5.05%
May 11, 2017May 11, 2017Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$0.84$20,950+40.58%
Jan 31, 2017Feb 02, 2017Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$1.12$1,829+12.33%
Jul 31, 2016Aug 02, 2016Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$4.29$1,810+4.06%
Jan 31, 2016Feb 01, 2016Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$4.38$1,774+4.07%
Aug 19, 2015Aug 21, 2015Phillips Barclay A
SVP
CFO
SellNovavax IncNVAX$13.06$374,323-75.79%
Jul 31, 2015Aug 04, 2015Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$2.28$1,742+1.98%
Jan 31, 2015Feb 03, 2015Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$2.28$19,125+18.46%
Oct 03, 2014Oct 06, 2014Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$4.11$20,550+14.86%
Jul 31, 2014Aug 04, 2014Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$2.28$20,037+27.09%
Mar 25, 2014Mar 25, 2014Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$4.25$21,225+25.17%
Mar 25, 2014Mar 25, 2014Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$4.25$21,225+25.17%
Jan 31, 2014Feb 04, 2014Phillips Barclay A
SVP
CFO
BuyNovavax IncNVAX$2.29$22,598+50.00%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.